Screening for Anxiety and Depressive Symptoms in Type 2 Diabetes Using Patient-Reported Outcome Measures: Comparative Performance of the EQ-5D-5L and SF-12v2

Screening for Anxiety and Depressive Symptoms in Type 2 Diabetes Using Patient-Reported Outcome Measures: Comparative Performance of the EQ-5D-5L and SF-12v2

Objective. To evaluate the performance of EQ-5D-5L (EuroQol Five-Dimension, Five-Level Questionnaire) and SF-12-v2 (12-item Medical Outcomes Health Survey–Short Form, Version 2) in screening for anxiety and depressive symptoms in adults with type 2 diabetes. Methods. Cross-sectional data from a popu...

Full description

Bibliographic Details
Main Authors: Fatima Al Sayah, Arto Ohinmaa, Jeffrey A. Johnson
Format: Article
Language:English
Published: SAGE Publishing 2018-09-01
Series:MDM Policy & Practice
Online Access:https://doi.org/10.1177/2381468318799361

Similar Items

Similar Items